Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Expensive Rocket
20642.0000 -460.00 (-2.18%)
NSE Nov 20, 2026 15:31 PM
Volume: 37,328
 

20642.00
-2.18%
HDFC Securities
Maintain BUY with a TP of Rs 914 (16x FY20E EPS) Neuland Labs (NLL) delivered poor performance in its 1QFY19 results. Revenue grew 31%YoY to Rs 1.54bn (down 4%QoQ) and EBITDA at Rs 90mn was up 11.3%YoY (sequential drop of 52%) with margin at 5.8% (declining by ~100bpsYoY). PAT reduced by 37%YoY and 95%QoQ, standing at Rs 4.1mn.
Neuland Laboratories Ltd.'s price crossed below 50Day SMA today
More from Neuland Laboratories Ltd.
Recommended